IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q1 2026 Holdings

Filed 2026-04-21 | 4 holdings | $981.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$792.9M19,963,15780.8%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$85.6M2,674,1828.7%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$82.9M7,464,5728.4%
Aura Biosciences Inc(AURA)COM05153U107$20.3M3,039,8922.1%